Source Bioscience PLC Company Profile (LON:SBS)

Analyst Ratings

Consensus Ratings for Source Bioscience PLC (LON:SBS) (?)
Ratings Breakdown: No ratings tracked in the last 12 months.
Consensus Rating:N/A (Score: NaN)
Consensus Price Target: N/A

Analysts' Ratings History for Source Bioscience PLC (LON:SBS)
Show:
DateFirmActionRatingPrice TargetActions
1/29/2016N+1 SingerReiterated RatingcorporateView Rating Details  Tweet This Rating  Share This Rating on StockTwits
(Data available from 7/28/2014 forward)

Earnings

Earnings History for Source Bioscience PLC (LON:SBS)
No earnings announcements for this company have been tracked by MarketBeat.com

Estimates

Earnings Estimates for Source Bioscience PLC (LON:SBS)
No earnings estimates for this company have been tracked by MarketBeat.com

Dividends

Dividend History for Source Bioscience PLC (LON:SBS)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for Source Bioscience PLC (LON:SBS)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionActions
10/14/2015Turnbull,LaurieInsiderSell2,000,000GBX 17£340,000Tweet This Trade  Share This Trade on StockTwits
9/8/2015Ash,Dr NickInsiderSell1,454,243GBX 17£247,221.31Tweet This Trade  Share This Trade on StockTwits
(Data available from 1/1/2013 forward)

Headlines

Latest Headlines for Source Bioscience PLC (LON:SBS)
DateHeadline
07/15/16 09:58 AMForm 8.5 (EPT/RI) - Source Bioscience - Amendment - [at noodls] - FORM 8.5 (EPT/RI) PUBLIC DEALING DISCLOSURE BY AN EXEMPT PRINCIPAL TRADER WITH RECOGNISED IN,TERMEDIARY STATUS DEALING IN A CLIENT-SERVING CAPACITY Rule 8.5 of the Takeover Code (the 'Code') 1. KEY INFORMATION ...
07/15/16 09:28 AMForm 8.5 (EPT/RI) -Source Bioscience Amendment - [at noodls] - FORM 8.5 (EPT/RI) PUBLIC DEALING DISCLOSURE BY AN EXEMPT PRINCIPAL TRADER WITH RECOGNISED IN,TERMEDIARY STATUS DEALING IN A CLIENT-SERVING CAPACITY Rule 8.5 of the Takeover Code (the 'Code') 1. KEY INFORMATION ...
06/08/16 03:38 AMForm 8.5 (EPT/RI) - Source Bioscience Plc - [at noodls] - FORM 8.5 (EPT/RI) PUBLIC DEALING DISCLOSURE BY AN EXEMPT PRINCIPAL TRADER WITH RECOGNISED IN,TERMEDIARY STATUS DEALING IN A CLIENT-SERVING CAPACITY Rule 8.5 of the Takeover Code (the 'Code') 1. KEY INFORMATION ...
06/06/16 10:08 AMForm 8 (OPD) offeror - Source Bioscience plc - [at noodls] - FORM 8 (OPD) PUBLIC OPENING POSITION DISCLOSURE BY A PARTY TO AN OFFER Rules 8.1 and 8.2 of the Takeover Code (the 'Code') 1. KEY INFORMATION (a) Full name of discloser: Harwood Capital LLP ('Harwood Capital') ...
06/03/16 06:55 PMContinental Investment, Harwood To Offer To Buy Source BioScience For 18p/share
06/03/16 08:55 AMForm 8.3 - Source BioScience Plc - [at noodls] - FORM 8.3 PUBLIC OPENING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the 'Code') 1. KEY INFORMATION (a) Full name of discloser: Legal ...
06/03/16 01:45 AMResponse to statement - [at noodls] - NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS ...
06/03/16 01:15 AMStatement re Possible Offer for Source BioScience - [at noodls] - NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS ...
05/13/16 06:10 AMSource Bioscience : Notice of AGM - Source BioScience plc (LSE: SBS) is a trusted provider of state of the art Laboratory Services and Products to the healthcare and clinical, life and applied sciences and biopharma industries. It is an international business operating ten state of the art ...
04/20/16 12:52 AMSource BioScience Plc :SBS-GB: Earnings Analysis: For the six months ended December 31, 2015 -
04/20/16 12:27 AMSource BioScience Plc :SBS-GB: Earnings Analysis: 2015 By the Numbers -
03/22/16 07:42 AMSource BioScience plc: Final Results -
03/22/16 02:22 AMPreliminary results for the year ended 31 December 2015 - [at noodls] - Microsoft Word - SBS Preliminary Announcement 31 December 2015 (2) 22 March 2016 Source BioScience plc ("Source BioScience" or "the Group") PRELIMINARY RESULTS FOR THE YEAR ENDED 31 ...
03/09/16 11:51 AMSource BioScience schedules FY results - Source BioScience will be announcing its preliminary results for the year ended 31 December on 22 March. At 4:00pm: (LON:SBS) Source BioScience PLC share price was 0p at 14.63p Story provided by StockMarketWire.com
02/20/16 10:58 AMNow Available: Source BioScience Plc (SBS) - Medical Equipment - Deals and Alliances Profile - (live-PR.com) - Source BioScience Plc (Source BioScience) is a biotechnology company that provides genetic analysis, stability storage and diagnostic services. The company's life science products include antibodies, clones, molecular and cellular biology ...
11/30/15 10:09 AMSource BioScience Plc – Value Analysis (LONDON:SBS) : November 30, 2015 -
11/20/15 07:03 AMOryx International outperforms benchmarks in the first half -
11/12/15 05:46 AMHoldings in Company (1) - [at noodls] - Microsoft Word - TR1 Source Bioscience plc 20151106 HV TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARESi 1. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached: ...
11/02/15 09:36 AMAdditional Listing on Exercise of Share Options - [at noodls] - Microsoft Word - Additional Listing November 2015 2 November 2015 Source BioScience plc (or 'the Company') Source BioScience plc (LSE: SBS) announces that it has issued 124,564 new Ordinary Shares of 2 ...
10/14/15 10:53 AMQuiet day for director dealings -

Social

About Source Bioscience PLC

Source BioScience plc is a United Kingdom-based provider of laboratory services and products to the healthcare and clinical, life and applied sciences and biopharma industries. The company operates its business in three segments: Healthcare, LifeSciences and Stability & Bio Storage. Its Healthcare segment comprises diagnostic services, including testing for cancer and infectious disease, and a portfolio of laboratory and clinical products, including cervical cancer screening in addition to blood and tissue serology reagents. Its LifeSciences segment provides deoxyribonucleic acid (DNA) sequencing services and related products, delivered by its international network of laboratories and distributors to academic research groups, biotechnology and pharmaceutical companies. Stability & Bio Storage segment provides support for drug discovery, from biomarker discovery and clinical trial services through to stability storage and sample archiving under environmentally controlled conditions.

Industry, Sector and Symbol:
  • Sector: N/A
  • Industry: N/A
  • Sub-Industry: N/A
  • Exchange: LON
  • Symbol: SBS
  • CUSIP:
Key Metrics:
  • Previous Close: $0.23
  • 50 Day Moving Average: $17.416
  • 200 Day Moving Average: $16.208
  • P/E Ratio: 44.062
  • P/E Growth: 0.000
  • Market Cap: $61.56M
  • Current Year EPS Consensus Estimate: $1.000 EPS
  • Next Year EPS Consensus Estimate: $N/A EPS
Additional Links: